Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    Ruby Khatun Khatun
    Ruby Khatun Khatun
      • Home
      • Ruby Khatun Khatun

      Articles By : Ruby Khatun Khatun

      No condom ads on TV between 6 am to 10 pm

      No condom ads on TV between 6 am to 10 pm

      Ruby Khatun Khatun12 Dec 2017 4:37 PM IST
      New Delhi: The National Commission for Protection of Child Rights (NCPCR) today welcomed the order of the government asking television channels not to...
      Suven gets product patents from India, US

      Suven gets product patents from India, US

      Ruby Khatun Khatun12 Dec 2017 11:00 AM IST
      New Delhi: Suven Life Sciences has secured a product patent each from India and the US for treatment of disorders associated with neurodegenerative...
      Alembic Pharma associate co gets USFDA fast track designation for cancer drug

      Alembic Pharma associate co gets USFDA fast track designation for cancer drug

      Ruby Khatun Khatun12 Dec 2017 10:45 AM IST
      New Delhi: Drug firm Alembic Pharmaceuticals said the US health regulator has granted fast track designation to its associate company Rhizen...
      Granules arm completes audit with USFDA

      Granules' arm completes audit with USFDA

      Ruby Khatun Khatun12 Dec 2017 10:30 AM IST
      New Delhi: Pharma firm Granules India said its US subsidiary has received an observation from the USFDA on completion of the inspection."Granules...
      Novo Nordisk, Torrent expand insulin capacity in Gujarat by 35 percent

      Novo Nordisk, Torrent expand insulin capacity in Gujarat by 35 percent

      Ruby Khatun Khatun12 Dec 2017 10:15 AM IST
      Ahmedabad: World leader in diabetes care, the Danish pharma major Novo Nordisk, in partnership with Torrent Pharma, opened an enhanced facility in...
      Roche lymphoma drug drives high remission rate, longer survival: study

      Roche lymphoma drug drives high remission rate, longer survival: study

      Ruby Khatun Khatun12 Dec 2017 10:00 AM IST
      An experimental Roche Holding AG drug, added to standard therapy, led to a far higher rate of remission and helped patients with an advanced,...
      Bill Gates acknowledges Hester for developing a Newcastle Disease Vaccine

      Bill Gates acknowledges Hester for developing a Newcastle Disease Vaccine

      Ruby Khatun Khatun12 Dec 2017 9:45 AM IST
      Bill Gates mentioned Hester’s name in his speech at AP AgTech Summit 2017 in Visakhapatnam on 17 November 2017.Gates referred to the Bill &...
      800 blood sample kits with Govt show only one Blood Group, Investigation against Manufacturer launched

      800 blood sample kits with Govt show only one Blood Group, Investigation against Manufacturer launched

      Ruby Khatun Khatun11 Dec 2017 5:27 PM IST
      BIJNOR: A Bangalore based company is being enquired by Ashutosh Mishra, a drug inspector in Bijnor district after 800 blood sample collecting kits...
      Zydus gets USFDA nod for schizophrenia drug

      Zydus gets USFDA nod for schizophrenia drug

      Ruby Khatun Khatun11 Dec 2017 11:00 AM IST
      New Delhi: Zydus Pharmaceuticals (USA) Inc has received final approval from the US health regulator to market Clozapine tablets, used in the treatment...
      Novartis CAR-T therapy leads to durable response in lymphoma study

      Novartis CAR-T therapy leads to durable response in lymphoma study

      Ruby Khatun Khatun11 Dec 2017 10:45 AM IST
      Patients with an advanced form of an aggressive blood cancer who had initially responded to Novartis' new type of gene-modifying immunotherapy...
      Gilead Sciences new drug keeps 56 percent of lymphoma trial patients alive

      Gilead Sciences new drug keeps 56 percent of lymphoma trial patients alive

      Ruby Khatun Khatun11 Dec 2017 10:30 AM IST
      More than half of trial patients with an advanced, aggressive form of blood cancer lived for at least a year after one-time treatment with Yescarta, a...
      CBI books Apollo Pharmacy in cheating case

      CBI books Apollo Pharmacy in cheating case

      Ruby Khatun Khatun11 Dec 2017 10:20 AM IST
      New Delhi: The CBI has booked Apollo Pharmacy, a unit of Apollo Hospitals, in a case of cheating and corruption.The investigative agency, in a recent...
      PrevNext

      Popular Stories

      • Email: info@medicaldialogues.in
      • Phone: 011 - 4372 0751

      Website Last Updated On : 13 Oct 2022 5:14 AM GMT
      Company
      • About Us
      • Contact Us
      • Our Team
      • Reach our Editor
      • Feedback
      • Submit Article
      Ads & Legal
      • Advertise
      • Advertise Policy
      • Terms and Conditions
      • Privacy Policy
      • Editorial Policy
      • Comments Policy
      • Disclamier
      Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

      Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

      © 2025 - Medical Dialogues. All Rights Reserved.
      Powered By: Hocalwire
      X
      We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok